#069 COVID Vaccine Myths, Questions, and Rumors with Rhonda Patrick and Roger Seheult
Dr. Rhonda Patrick, Dr. Roger Seheult, and Kyle Allred of MedCram engage in a comprehensive, merit-based discussion on COVID-19 vaccination. They cover vaccine safety, efficacy, risks vs. benefits, and address common concerns like myocarditis, long-haul COVID, spike protein, VAERS data, and ivermectin.
Deep Dive Analysis
16 Topic Outline
Vaccination in Young and Healthy Individuals
Comparing Myocarditis Risk: COVID-19 Infection vs. Vaccination
Understanding Long-Haul COVID and its Effects
Correct Interpretation of COVID-19 Death Certificates
Distinguishing Viral Spike Protein from Vaccine Spike Protein
Biodistribution of Vaccine Particles and Animal Study Misconceptions
How to Interpret VAERS Data and its Limitations
Addressing Concerns about Antibody-Dependent Enhancement (ADE)
COVID-19 Vaccines and Human Fertility
Can mRNA Vaccines Alter Human DNA?
Current Evidence and Limitations of Ivermectin for COVID-19
Delta Variant's Impact on Vaccine Efficacy and Transmission
Viral Evolution: Virulence vs. Immune Escape
The Role of T-Cell Immunity in COVID-19 Protection
Accelerated Vaccine Development: Safety and Historical Context
Future Potential of mRNA Technology Beyond COVID-19
7 Key Concepts
Pre-fusion Stabilization
A structural biology technique involving the insertion of two proline amino acids into viral spike proteins to lock them into a pre-fusion conformation. This prevents the spike protein from undergoing the conformational change needed to fuse with cell membranes, making it a safer and more effective target for vaccine-induced antibodies.
VAERS (Vaccine Adverse Event Reporting System)
A reporting system in the United States where medical professionals are legally required to report any serious adverse health events, including death, that occur after a COVID-19 vaccination, regardless of whether they believe the vaccine caused the event. This data is used to generate hypotheses but requires scientific analysis (stratification by age, gender, ethnicity, comparison to background rates) to draw conclusions about causality.
Antibody-Dependent Enhancement (ADE)
A phenomenon where antibodies generated against a pathogen are non-functional, binding to the pathogen but failing to neutralize it. Instead, these antibodies can activate other immune cells to become more aggressive, potentially causing more damage and leading to more severe disease than if the immune system had not encountered the pathogen before.
Swiss Cheese Model of Protection
A mental model illustrating that multiple layers of defense are needed to prevent an undesirable outcome, such as infection. Each layer has imperfections or 'holes,' but by stacking many layers with holes in different places, the overall likelihood of a problem getting through all layers is significantly reduced.
Overall Transmission
Refers to the transmission of a virus at the population level. If a treatment or vaccine prevents even a small percentage of people from becoming infected or ill, it reduces the total number of infections in the population, thereby reducing overall transmission.
Onward Transmission
Refers to the transmission of a virus from an infected individual to other individuals, typically through shedding of viral particles. This is the more commonly understood type of transmission at the individual level.
Viral Selective Pressure
The evolutionary force acting on viruses to favor traits that enhance their survival and reproduction. Viruses are primarily under selective pressure to become more transmissible, meaning they can spread more easily between hosts. Virulence (deadliness) is not directly selected for but can sometimes 'hitchhike' alongside increased transmissibility.
11 Questions Answered
Yes, because the Delta variant has changed the landscape, increasing hospitalization rates for younger populations, and the risk of myocarditis from COVID-19 infection is higher than from vaccination.
Yes, even individuals with mild or asymptomatic COVID-19 can develop post-COVID syndrome (long-haul COVID), experiencing symptoms like brain fog, racing heart, lethargy, and even brain atrophy or blood clots/strokes.
No, VAERS data is a reporting system, not a causal link. The reporting requirements for COVID-19 vaccines were expanded to include all serious adverse events regardless of suspected cause, and when compared to expected background death rates in the population, the reported deaths fall far below what would occur by chance.
No, the spike protein in mRNA vaccines is structurally different due to two proline amino acid insertions that lock it into a pre-fusion conformation, preventing it from undergoing the conformational changes that allow the viral spike protein to fuse with and damage cells.
No, current U.S. vaccines use pre-fusion stabilized spike proteins, which primarily generate neutralizing antibodies and avoid the production of post-fusion antibodies associated with ADE. Real-world data also shows vaccinated individuals have less severe disease, contradicting ADE.
No, studies from phase three trials, pregnancy registries, and reproductive medicine societies have shown no statistically significant difference in pregnancy rates, miscarriages, embryo implantation, or sperm parameters between vaccinated and unvaccinated individuals.
No, mRNA vaccines cannot alter human DNA because the mRNA does not enter the cell nucleus where DNA resides, nor does it contain the necessary enzymes (reverse transcriptase or integrase) to convert mRNA into DNA and integrate it into the genome.
While repurposed therapeutics like ivermectin are being studied, current high-quality data does not support claims that they are as effective as vaccines in preventing infection or severe disease. Relying solely on treatments is a 'Swiss cheese model' fallacy, as multiple layers of protection are best.
No, viruses are primarily under selective pressure to become more transmissible, not more virulent. Vaccines reduce viral replication and transmission, thereby reducing the opportunities for mutations that could lead to new variants, including potentially more virulent ones.
No, the development process was accelerated by running trials concurrently and government funding removing financial risks for manufacturing, but no critical steps (like animal studies or phase 1, 2, 3 trials) were skipped. The mRNA technology itself has also been researched and used in human clinical trials for decades.
Yes, while their efficacy against infection (and thus onward transmission) is reduced compared to earlier variants, they still significantly reduce overall transmission at a population level by preventing many infections. Vaccinated individuals also clear the virus faster and shed less infectious viral particles.
16 Actionable Insights
1. Prioritize COVID-19 Vaccination
Get vaccinated against COVID-19, even if young and healthy, because the Delta variant significantly increases hospitalization risk for younger populations, and the risk of myocarditis from infection is higher than from vaccination.
2. Beware of Long-Haul COVID
Be aware of the risk of long-haul COVID syndrome, including brain atrophy, blood clots, and strokes, even from mild or asymptomatic infections, as these can affect younger individuals and lead to long-term health issues.
3. Trust Accelerated Vaccine Development
Trust the accelerated development of COVID-19 vaccines; the process was expedited by removing financial barriers and running trials concurrently, not by skipping safety steps, and the underlying mRNA technology has been researched and used in human clinical trials for decades.
4. mRNA Vaccines Don’t Alter DNA
Dismiss concerns that mRNA vaccines alter human DNA; the biological mechanisms (lack of nuclear entry, reverse transcriptase, or integrase enzymes) make it biologically implausible, and it’s viruses themselves (like HIV) that can alter DNA.
5. Dismiss Antibody-Dependent Enhancement (ADE)
Do not be concerned about antibody-dependent enhancement (ADE) with current COVID-19 vaccines, as their design prevents the generation of ADE-causing antibodies, and real-world data shows vaccinated individuals have less severe disease.
6. Trust Vaccine Fertility Data
Be reassured that current data from clinical trials and real-world studies indicates no significant negative effect of COVID-19 vaccines on human fertility in men or women, nor on pregnancy outcomes.
7. Interpret VAERS Data Carefully
Do not directly interpret raw VAERS data to conclude vaccine-caused deaths or adverse events, as it’s a reporting system with expanded requirements and reporting biases, requiring expert epidemiological analysis against background rates.
8. Avoid Misinterpreting Death Certificates
Do not misinterpret CDC death certificate data to conclude that COVID-19 only causes 5% of deaths or only kills people with multiple comorbidities, as the listed ‘comorbidities’ are often the direct fatal consequences of COVID-19.
9. Differentiate Vaccine Spike Protein
Understand that the spike protein in COVID-19 vaccines is structurally different from the SARS-CoV-2 viral spike protein, making comparisons of their dangers inaccurate; concerns about vaccine spike protein biodistribution are based on high-dose animal studies or unreliable human data.
10. Vaccines Reduce COVID-19 Transmission
Understand that COVID-19 vaccines, even with the Delta variant, still reduce overall transmission by preventing a significant percentage of infections, and also reduce onward transmission by leading to faster viral clearance and less infectious viral particles in breakthrough cases.
11. Virulence Not Selected For
Do not believe claims that COVID-19 vaccines make the virus more deadly or virulent; viruses evolve for transmissibility, not virulence, and variants typically emerge from unvaccinated populations where higher viral replication provides more opportunities for mutation.
12. Ivermectin Not Vaccine Alternative
Do not rely solely on ivermectin or other repurposed treatments as an alternative to vaccination; current evidence for ivermectin’s direct efficacy against COVID-19 is limited, often confounded, and does not compare to proven vaccine efficacy. Avoid self-medicating with veterinary formulations.
13. Adopt Swiss Cheese Model
Employ a ‘Swiss cheese model’ approach to protection against COVID-19, using multiple layers of defense (like vaccination, masks, and treatments) because each layer has ‘holes,’ and combining them offers better overall protection.
14. Optimize General Health
Optimize general health and immunity through lifestyle factors such as adequate sleep, sufficient vitamin D levels, regular exercise, stress reduction, and exposure to fresh air and sunlight, as these provide broad benefits beyond COVID-19.
15. Engage in Thoughtful Discussion
Put aside partisan thinking and approach discussions about COVID-19 with thoughtfulness, patience, and humility, especially when encountering differing viewpoints.
16. Seek Unbiased Information
Seek out unbiased, science-based information to understand the risks and benefits of COVID-19 vaccines and other health topics to make informed personal decisions, rather than relying on sensationalized or misleading claims.
8 Key Quotes
Discussing COVID-19 is tricky because getting the details right is so very important, and yet getting details right is exactly what is made worse when so many of us engage only in thinking that is biased by political partisanship.
Dr. Rhonda Patrick
If just 1% are going to die, that's 3.3 million people. And that's just the people who are dying. Let's talk about the people who are sick and need to be hospitalized because they can't breathe because of oxygenation. We only have under a million acute care beds in the United States. And so as a result of that, you are going to quickly overwhelm the healthcare system.
Dr. Roger Seheult
The burden of proof is on, you know, people making the claim that the spike protein from the mRNA vaccines is dangerous because some studies have shown that this spike protein from the SARS-CoV-2 by itself can be dangerous. You have to show that and it has not been shown.
Dr. Rhonda Patrick
The central dogma of molecular biology is that DNA goes to RNA, RNA goes to protein. And what we're doing with the vaccine is we're simply instructing the ribosomes, which reside in the outer portion of the cell, to make the protein.
Dr. Roger Seheult
The more slices of Swiss cheese you put in there, the less likely you're going to be able to find a hole that's going to get through all of those slices. And that's the general principle here that we see with the Swiss cheese model of making sure that we have the best protection we have to avoid the outcomes that we don't want to have.
Dr. Roger Seheult
There's just no evidence that ivermectin is going to protect you from infection and from severe disease as well as a vaccine. There's no evidence of that. And so don't make that claim. You know, make the claim for what the data speaks to.
Dr. Rhonda Patrick
Viruses, the selective pressure on viruses is to evolve to become more transmissible. They are not under a selection pressure to become more virulent. In other words, it's not in their best interest to kill their host.
Dr. Rhonda Patrick
The factories were being built at the same time that the phase one and two trials were being done. And why is that? Why were they able to do that? What the government did by stepping in and providing them money and resources and providing those barriers is they're saying, look, we'll give you the money to build the factories, realizing that if these phase one, two, and three trials are a bust, you're not going to be held liable for the amount of money that you've spent in building these factories that aren't going to do anything.
Dr. Roger Seheult